Clinical Trial Update: Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating whether conjugated linoleic acid (CLA) supplementation can modulate lipogenic pathways in breast cancer tissue; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Conjugated Linoleic Acid (Conjugated linoleic acid)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-04-01